These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26158644)

  • 1. Fine Tuning of a Type 1 Interferon Antagonist.
    Urin V; Levin D; Sharma N; Harari D; Schreiber G
    PLoS One; 2015; 10(7):e0130797. PubMed ID: 26158644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression.
    Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W
    Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted activities of type I interferon are revealed by a receptor antagonist.
    Levin D; Schneider WM; Hoffmann HH; Yarden G; Busetto AG; Manor O; Sharma N; Rice CM; Schreiber G
    Sci Signal; 2014 May; 7(327):ra50. PubMed ID: 24866020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
    Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
    J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies.
    Ning YJ; Feng K; Min YQ; Cao WC; Wang M; Deng F; Hu Z; Wang H
    J Virol; 2015 Apr; 89(8):4227-36. PubMed ID: 25631085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.
    Arimoto KI; Löchte S; Stoner SA; Burkart C; Zhang Y; Miyauchi S; Wilmes S; Fan JB; Heinisch JJ; Li Z; Yan M; Pellegrini S; Colland F; Piehler J; Zhang DE
    Nat Struct Mol Biol; 2017 Mar; 24(3):279-289. PubMed ID: 28165510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs.
    Zhao W; Lee C; Piganis R; Plumlee C; de Weerd N; Hertzog PJ; Schindler C
    J Immunol; 2008 Apr; 180(8):5483-9. PubMed ID: 18390731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cytokinome Analysis for Interferon Response.
    Al-Yahya S; Mahmoud L; Al-Zoghaibi F; Al-Tuhami A; Amer H; Almajhdi FN; Polyak SJ; Khabar KS
    J Virol; 2015 Jul; 89(14):7108-19. PubMed ID: 25926649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
    Paulus C; Krauss S; Nevels M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells.
    Miyagi T; Gil MP; Wang X; Louten J; Chu WM; Biron CA
    J Exp Med; 2007 Oct; 204(10):2383-96. PubMed ID: 17846149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
    He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
    Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of oligomerization-deficient Stat1.
    Vinkemeier U; Meyer T
    Genome Inform; 2005; 16(1):44-8. PubMed ID: 16362905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R.
    Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR
    J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.